Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GENEREX BIOTECHNOLOGY CORP (GNBT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsApr-30-21Jan-31-21Oct-31-20Jul-31-20Apr-30-20Jan-31-20Oct-31-19Jul-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  0.00.00.0-33.30.00.00.0-9.3
Depreciation and amortization   [+]0.30.30.30.20.20.20.2-0.1
Asset impairment charges         0.2
Stock-based compensation  0.40.51.20.40.40.40.81.5
Deferred taxes  2.03.073.0-67.3   6.6
Change in working capital   [+]2.45.99.64.61.91.42.12.4
Other operating activities  -4.5-10.6-85.494.7-3.4-4.8-5.0-2.7
Cash from operations  0.6-1.0-1.3-0.6-0.9-2.8-1.8-1.5
   
Capital expenditures   [+]0.00.00.00.00.00.00.00.0
Other cash from investing        0.0 
Cash from investing  0.00.00.00.00.00.00.00.0
   
Issuance of common stock, net  0.70.82.2  0.1  
Other cash from financing  -0.2-0.1-0.10.21.02.42.00.4
Cash from financing  0.50.72.20.21.02.52.00.4
   
Free cash flow  0.6-1.0-1.3-0.6-0.9-2.8-1.8-1.5
        Per share (diluted)  $0.00($0.01)($0.01)($0.01)($0.01)($0.04)($0.03)($0.02)
   
Cash paid for interest    0.1   0.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy